Chronic hepatitis infection is associated with extrahepatic cancer development: A nationwide population-based study in Taiwan

BMC Cancer

Volumn 16, Issue 1, 2016, Pages

  Kamiza, Abram Bunya ^a   Su, Fu Hsiung ^a,b,c   Wang, Wen Chang ^a   Sung, Fung Chang ^d,e   Chang, Shih Ni ^d,e   Yeh, Chih Ching ^a,f  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c FLINDERS UNIVERSITY   (Australia)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cancer risk; Hepatitis B virus; Hepatitis C virus; Taiwan

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER RISK; CARCINOGENESIS; CHRONIC HEPATITIS; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CANCER; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; KIDNEY CANCER; LIVER CANCER; LIVER CARCINOGENESIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; TAIWAN; CHRONIC DISEASE; CHRONIC HEPATITIS B; COMORBIDITY; COMPLICATION; HEALTH SURVEY; HEPATITIS C; INCIDENCE; LIVER NEOPLASMS; MIDDLE AGED; MIXED INFECTION; NEOPLASMS; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY; VIROLOGY; VIRUS HEPATITIS;

BIOLOGICAL MARKER;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CHRONIC DISEASE; COINFECTION; COMORBIDITY; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; TAIWAN;

EID: 84994442675     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2918-5     Document Type: Article

References (35)

1. World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec. 2009;40:405-20.
2. World Health Organization. Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection. Geneva: World Health Organization; 2014. Available from: http://www.ncbi.nlm.nih.gov/books/NBK263483/. Accessed 4 Nov 2015.
3. Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut. 1996;38 Suppl 2:S18-23.
4. Huang H, Hu XF, Zhao FH, Garland SM, Bhatla N, Qiao YL. Estimation of Cancer Burden Attributable to Infection in Asia. J Epidemiol. 2015;25:626-38.
5. Lok ASF. Chronic hepatitis B. N Engl J Med. 2002;346:1682-3.
6. Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529-38.
7. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst. 1990;82:1038-41.
8. Stroffolini T, Chiaramonte M, Tiribelli C, Villa E, Simonetti RG, Rapicetta M, et al. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J Hepatol. 1992;16:360-3.
9. Hadziyannis S, Tabor E, Kaklamani E, Tzonou A, Stuver S, Tassopoulos N, et al. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma. Int J Cancer J. 1995;60:627-31.
10. Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, et al. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study. Liver Int. 2010;30:423-9.
11. Fwu CW, Chien YC, Nelson KE, Kirk GD, You SL, Kuo HS, et al. Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from Taiwan. J Infect Dis. 2010;201:1016-23.
12. Engels EA, Cho ER, Jee SH. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol. 2010;11:827-34.
13. Fwu CW, Chien YC, You SL, Nelson KE, Kirk GD, Kuo HS, et al. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Hepatol Baltim Md. 2011;53:1217-25.
14. Ulcickas Yood M, Quesenberry CP, Guo D, Caldwell C, Wells K, Shan J, et al. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatol Baltim Md. 2007;46:107-12.
15. Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol. 2006;45:197-203.
16. Sundquist K, Sundquist J, Ji J. Risk of hepatocellular carcinoma and cancers at other sites among patients diagnosed with chronic hepatitis B virus infection in Sweden. J Med Virol. 2014;86:18-22.
17. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, et al. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer. 2008;122:1849-53.
18. Patel BB, Lipka S, Shen H, Davis-Yadley AH, Viswanathan P. Establishing the link between hepatitis B virus infection and colorectal adenoma. J Gastrointest Oncol. 2015;6:492-7.
19. Tsai MC, Kee KM, Chen YD, Lin LC, Tsai LS, Chen HH, et al. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan. J Gastroenterol Hepatol. 2007;22:92-8.
20. Liang SH, Chen TJ, Lee SSJ, Tseng FC, Huang CK, Lai CH, et al. Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection. J Acquir Immune Defic Syndr. 2010;54:122-8.
21. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:e609-16.
22. Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer. 2005;92:607-12.
23. Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, et al. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol. 1998;27:574-8.
24. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer J. 1998;75:347-54.
25. Blum HE, Moradpour D. Viral pathogenesis of hepatocellular carcinoma. J Gastroenterol Hepatol. 2002;17 Suppl 3:413-20.
26. Xu JH, Fu JJ, Wang XL, Zhu JY, Ye XH, Chen SD. Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies. World J Gastroenterol. 2013;19:4234-41.
27. Fiorino S, Chili E, Bacchi-Reggiani L, Masetti M, Deleonardi G, Grondona AG, et al. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: a systematic review and meta-analysis. Pancreatol. 2013;13:147-60.
28. Luo G, Hao NB, Hu CJ, Yong X, Lü MH, Cheng BJ, et al. HBV infection increases the risk of pancreatic cancer: a meta-analysis. Cancer Causes Control. 2013;24:529-37.
29. Rustagi T, Zarookian EI, Qasba O, Diez LF. Chronic hepatitis C as a risk factor for colorectal adenoma. Int J Colorectal Dis. 2014;29:75-80.
30. Hsieh A, Kim HS, Lim SO, Yu DY, Jung G. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling. Cancer Lett. 2011;300:162-72.
31. Xu F, Zhu X, Han T, You X, Liu F, Ye L, et al. The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1. Int J Oncol. 2014;45:255-63.
32. Mahale P, Sturgis EM, Tweardy DJ, Ariza-Heredia EJ, Torres HA. Association Between Hepatitis C Virus and Head and Neck Cancers. J Natl Cancer Inst. 2016;108:djw035.
33. Lee MH, Yang HI, Lu SN, Jen CL, You SL, Wang LY, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012;206:469-77.
34. Nyberg AH, Chung JW, Shi JM, Cheetham TC, Chiang KM, Haque R, et al. Increased cancer rates in patients with chronic hepatitis C: An analysis of the cancer registry in a large U.S. health maintenance organization. Vienna: 50th Annual Meeting of the European Association for the Study of the Liver; 2015.
35. Allison RD, Tong X, Moorman AC, Ly KN, Rupp L, Xu F, et al. Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010. J Hepatol. 2015;63:822-8.